Latest news articles

Added 2 days ago Drug news

Xtandi sNDA filed with FDA for metastatic hormone-sensitive prostate cancer.- Astellas + Pfizer

Astellas Pharma and Pfizer announced that the FDA has accepted for review the filing of a supplemental New Drug Application...

Added 17 days ago Drug news

Lynparza met the primary endpoint of significantly increasing the time prostate cancer patients selected for BRCA1/2 or ATM mutations live without radiographic disease progression.

AstraZeneca and MSD Inc., Kenilworth, N.J., announced positive results from the Phase III PROfound trial of Lynparza (olaparib) in men...

Added 1 month ago Drug news

FDA approves Otelza for the treatment of oral ulcers associated with Behçet’s disease.

Celgene Corporation announced that the FDA has approved Otezla (apremilast) 30 mg twice daily (BID) for the treatment of adult...

Search all news articles for Men's health/andrology
 

 

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Chronic Lymphocytic Leukaemia (CLL)

Chronic Lymphocytic Leukaemia (CLL)

Refine your knowledge of chronic lymphocytic leukaemia (CLL) with information on pathophysiology, diagnosis, treatment options and more

+ 1 more

Transplantation

Transplantation

See information on best practice in solid organ transplantation, and expert discussions on related hot topics.

Psoriasis

Psoriasis

See information on psoriasis pathophysiology, signs and symptoms, comorbidities, treatment options, and more.

+ 2 more

Load more

 

Guidelines

Prostate cancer: diagnosis and management

This guideline covers the diagnosis and management of prostate cancer in secondary care, including information on the best way to diagnose and identify different stages of the disease, and how to manage adverse effects of treatment.

Added 5 years ago

EAU Guidelines on Prostate Cancer

The European Association of Urology (EAU) Guidelines Group for Prostate Cancer have prepared this guidelines document to assist medical professionals assess the evidence-based management of prostate cancer (PCa).

Added 3 years ago

Guidelines on Penile Cancer

The European Association of Urology (EAU) Guidelines on Penile Cancer provides up-to-date information on the diagnosis and management of penile squamous cell carcinoma (SCC).

Added 5 years ago

Search all guidelines for Men's health/andrology
 

Journal articles

Metabolic Biosynthesis Pathways Identified from Fecal Microbiome Associated with Prostate Cancer.

Objective: To investigate gut bacterial diversity, identify specific metabolic pathways associated with disease, and develop a microbiome risk profile for prostate cancer.

Added 3 months ago

The Role of Gut Microbiome in the Pathogenesis of Prostate Cancer: A Prospective, Pilot Study.

Objective: To elucidate potential biomarkers or mechanistic principles involved with the gut microbiota and its impact on prostate cancer pathogenesis.

Added 3 months ago

Apalutamide and its use in the treatment of prostate cancer.

High-risk nonmetastatic castration-resistant prostate cancer is a lethal disease that previously lacked clear treatment options. Progression to bone metastases is associated with significant morbidity and high cost.

Added 3 months ago

Search all journal articles for Men's health/andrology
 

Clinical trials

A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer

The purpose of this study is to evaluate the effectiveness of niraparib in combination with abiraterone acetate and prednisone (AA-P) compared to AA-P plus placebo.

Added 3 months ago

A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer

This study is being done to see how safe and effective abemaciclib is when given together with abiraterone acetate plus prednisone in participants with metastatic castration resistant prostate cancer.

Added 3 months ago

Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer

The purpose of this study is to evaluate the efficacy and safety (including evaluating side effects) of combination of olaparib and abiraterone versus placebo and abiraterone in patients with metastatic castration-resistant prostate cancer...

Added 3 months ago

Search all clinical trials for Men's health/andrology
 

Blog Posts

Monica Caliber

Hypogonadism – why important to diagnose and treat?

Posted 3 years ago

Most clinicians and patients think that the purpose of treating hypogonadism is to merely relieve symptoms. However, this only scratches the surface... 

Hugh Harvey

Metrics Madness

Posted 3 years ago

You shouldn't judge a book by its cover. That much is true, but it's also common sense not to judge a book by measuring the whiteness of its pages, or the amount of hamsters you can place on it. So why do we measure the fabulous NHS with nonsense metrics?

My Urology Doc

Men's Health: A Forgotten Topic

Posted 4 years ago

Men's health is a forgotten topic. To be honest, we men are mostly to blame. We've clung to our masculine misconceptions and repeatedly refused to engage the healthcare community. Who can blame us, we're invincible and we're going to live forever, right? Well, not exactly. Let's look at some of the reasons men's health is one of the least engaged topics in healthcare. 

CME

Managing the side effects of treatment for prostate cancer

Accrediting body
BMJ Learning - British Medical Learning
Credits available
1
Registration required
1
Subscription fee
90

Managing patients at risk of prostate cancer

Accrediting body
BMJ Learning - British Medical Learning
Credits available
1
Registration required
1
Subscription fee
90

Guidance update: latest NICE guidelines on prostate cancer

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
1
Registration required
1
Subscription fee
154.8
Search all CME for Men's health/andrology